Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

IN inhibitors

In styrene service, vapor may condense in flame arresters, and the liquid formed is low in inhibitor. Liquid may polymerize and plug off the arrester. Possible solutions include cleaning the arrester frequently or using a PVRV (pressure-vacuum relief valve). [Pg.2335]

In general the efficiency increases with an increase in inhibitor concentration—a typical good inhibitor gives 95% inhibition at a concentration of 0-008% and 90% at 0-004%. Provided the inhibitor is stable, increase in temperature usually increases the efficiency although the actual acid attack may be greater. A change in acid concentration, or in type of steel, may also alter the efficiency. Thus, the conditions of a laboratory determination of efficiency should closely simulate the conditions expected in commercial practice. [Pg.295]

Esser, V., Britton, C.H., Weiss, B.C., Foster, D.W. McGarry, J.D. (1993). Cloning, sequencing and expression of a cDNA encoding rat liver carnitine palmitoyltransferase 1. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J. Biol. Chem. 268, 5817-5822. [Pg.152]

These three classes of inhibition can be distinguished by virtue of the effect of variations in inhibitor concentration on the slopes and intercepts of reciprocal plots. For competitive inhibition only the slope varies. For uncompetitive inhibition only the intercept varies, while for noncompetitive inhibition both the slope and the intercept vary. [Pg.232]

The Influence of Environmental Factors on Enzyme Kinetics. Because enzymes are proteins, they are unusually sensitive to changes in their environment. This is true not only with regard to variations in inhibitor concentrations, but also with respect to variations in pH and temperature. Most enzymes are efficient catalysts only within relatively narrow ranges of pH and temperature. [Pg.232]

Inhibited monomer was transferred from a steel drum into a 4 1 clear glass bottle exposed to sunlight in a laboratory in which the ambient temperature was temporarily higher than usual. Exothermic polymerisation set in and caused the bottle to burst. Precautions recommended included increase in inhibitor concentration tenfold (to 200 ppm) for laboratory-stored samples, and use of metal or brown glass containers. See Other POLYMERISATION INCIDENTS... [Pg.626]

It took nearly a decade from the time the first purified IN protein was reported to the elucidation of the basic pharmacophore through the discovery of diketo acids (DKAs) and acid isostere analogs which were nearly simultaneously reported by independent groups [7]. Examples of these early generation IN inhibitors (INIs) are shown in Figure 1. [Pg.264]

Figure 3.14 shows the results of mathematical modeling experiments that simulate the ALIS response for a protein-ligand complex versus time when subjected to changes in inhibitor concentration and variation in other parameters. Figure 3.14A models a system consisting of 5 xM protein and 1 pM ligand with typical association and dissociation rates (ks.on=0-l s, ks-off = 0.01 s ... [Pg.145]

A limited amount of work was also conducted by the group of Schultz to investigate the potential of N-formyl hydroxylamine head group to inhibit HDAC. This bidentate chelating moiety was used successfully in inhibitors of angiotensin converting enzyme and neural endopeptidase, however, in the case of HDAC a 50-fold loss in activity was observed vdth this group (17a-c) [33]. [Pg.194]

WARNING Renal impair is the major tox foUow administration instructions Uses CMV retinitis w/ HIV Action Selective inhibition of viral DNA synth Dose Rx 5 mg/kg IV over 1 h once/wk for 2 wk w/ probenecid Maint 5 mg/kg IV once/2 wk w/ probenecid (2 g PO 3 h prior to cidofovir, then 1 g PO at 2 h 8 h after cidofovir) X in renal impair Caution [C, -] Contra Probenecid or sulfa allergy Disp Inj SE Renal tox, chills, fever, HA, NA /D, thrombocytopenia, neutropenia Interactions t Nephrotox W/ aminoglycosides, amphot icin B, foscar-net, IV pentamidine, NSAIDs, vancomycin t effects W/zidovudine EMS Monitor ECG for hypocalcemia (t QT int val) and hypokalemia (flattened T waves) OD May cause renal failure hydration may be effective in reducing drug levels/effects Cilostazol (Pletal) TAntiplatelet, Arterial Vasodilator/ Phosphodiesterase Inhibitor] Uses Reduce Sxs of intermittent claudication Action Phosphodiesterase in inhibitor t s cAMP in pits blood vessels, vasodilation inhibit pit aggregation Dose 100 mg PO bid, 1/2 h before or 2 h after breakfast dinner Caution [C, +/-] Contra CHE, hemostatic disorders. [Pg.111]

The acidic character of fluorinated alcohols, and consequently the excellent ability to donate hydrogen bonds, justifies their interest as central peptidomimetic units in inhibitors of serine and aspartyl proteases [2, p. 59], An enhancement of... [Pg.560]

R. Zamboni, Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K, Bioorg. Med. Chem. Lett. 15 (2005) 4741-4744. [Pg.615]

We subjected a segment of the petiole of the lowest leaf of several 3 leaf stage tomato plants, to a hot air jet to destroy the phloem. Within an hour the Injured petiole segments had dried to form the thin strands of xylem. As before, this treatment did not release PIIF Into the plant (Table II, treatment 3) while the leaf Itself (leaf 1) accumulated considerable Inhibitor I. Subsequent wounding of leaves whose phloem had been destroyed (Table II, treatment 4) did not result In Inhibitor I accumulation In adjacent leaves. Indicating that the phloem destruction had blocked Its transport out of the wounded leaf. [Pg.109]

Cory, J. G. (1989). Role of ribonucleotide reductase in cell division. In Inhibitors of Ribonucleoside Diphosphate Reductase Activity (J. G. Cory and A. H. Cory, eds.), pp. 1-16. Pergamon, New York. [Pg.253]

Unactivated states of the protein kinases have also been targeted in inhibitor design. In fact, five of the eight approved small molecule drugs have been reported to target the unactivated form of the enzyme (3). Two characterized, unactivated forms are the DFG-out (4, 5) and the aC-Glu-out conformations... [Pg.282]


See other pages where IN inhibitors is mentioned: [Pg.341]    [Pg.798]    [Pg.11]    [Pg.126]    [Pg.162]    [Pg.15]    [Pg.71]    [Pg.165]    [Pg.266]    [Pg.118]    [Pg.265]    [Pg.142]    [Pg.177]    [Pg.28]    [Pg.111]    [Pg.116]    [Pg.339]    [Pg.263]    [Pg.51]    [Pg.41]    [Pg.202]    [Pg.151]    [Pg.503]    [Pg.211]    [Pg.116]    [Pg.120]    [Pg.401]    [Pg.281]    [Pg.59]   
See also in sourсe #XX -- [ Pg.264 , Pg.265 , Pg.268 , Pg.272 ]




SEARCH



An irreversible cholinesterase inhibitor in white clover

Angiotensin-converting enzyme inhibitors in acute coronary syndromes

Angiotensin-converting enzyme inhibitors in heart failure

Angiotensin-converting enzyme inhibitors in hypertension

Aromatase inhibitors in breast cancer

Binding sites of nucleotides and inhibitors in

COMT inhibitors in Parkinson’s disease

COX/LOX dual inhibitors role in angiotensin Il-induced

COX/LOX dual inhibitors role in coronary vasoconstrictio

Case 2 Integrated Michaelis-Menten Equation in the Presence of Substrate Inhibitor

Characterization of an unstable process impurity in the protease inhibitor Tipranavir

Cholinesterase inhibitor in clover

Cholinesterase inhibitors in Alzheimer’s disease

Daklinza) The First-in-Class HCV NS5A Replication Complex Inhibitor

Development Process of ACE Inhibitors in Hypertension

Electrochemical Polarization Study of Corrosion Inhibitors in Cu CMP Slurry

Enzyme Kinetics in the Presence of an Inhibitor

Enzyme inhibitors in foods

Epigenetic Targets in Drug Discovery Cell-Based Assays for HDAC Inhibitor Hit Validation

Evaluation of Enzyme Inhibitors in Drug Discovery, by Robert A. Copeland

HIV-1 IN inhibitor

HIV-1 IN inhibitor trifluoromethyl pharmacophore

HRV inhibitors in vitro

HRV replication inhibitor in vitro

Hyperforin inhibitors in depression

Inhibitor Structures in the SD Binding Niche

Inhibitors in Refineries and Petrochemical Plants

Inhibitors in foods

Inhibitors in polymerization

Inhibitors in potatoes

Inhibitors in study of enzyme mechanisms

Inhibitors in styrene monomer

Monoamine oxidase inhibitors in Parkinson’s disease

Monoamine oxidase inhibitors in depression

Monoamine oxidase inhibitors in posttraumatic stress disorder

Monoamine oxidase inhibitors in social anxiety disorder

Non-protein inhibitors in clinical trials

Nucleosides and Nucleotides in the Presence of Growth Inhibitors

Other Leads in the Area of Complex I Inhibitors

Plasminogen inhibitors role in tissue protection

Praseodymium-based inhibitors in epoxy polyamide primers

Prostaglandin inhibitors use in dental surgery

Prostaglandin inhibitors use in headache

Prostaglandin inhibitors use in osteoarthritis

Prostaglandin inhibitors use in rheumatism

Protease inhibitors in Alzheimer’s disease

Protease inhibitors in HIV infection

Protease inhibitors in cancer inflammatory diseas

Protease inhibitors in combination therapy

Protease inhibitors in protozoal infection

Protease inhibitors in viral infection

Proteasome inhibitors in cancer therapy

Proton pump inhibitors in GERD

Proton pump inhibitors in peptic ulcer disease

Rare earths as corrosion inhibitors in aqueous systems

Recent Advances in Inhibitor Design

Reverse transcriptase inhibitors in HIV infection

Safety of HMG-CoA Reductase Inhibitors in the Megatrials

Selective serotonin reuptake inhibitors in children

Selective serotonin reuptake inhibitors in children and adolescents

Selective serotonin reuptake inhibitors in obsessive-compulsive disorder

Situation of PS II Inhibitors in the EC Markets

Sofosbuvir (Sovaldi) The First-in-Class HCV NS5B Nucleotide Polymerase Inhibitor

Testing and analysis techniques in rare earth inhibitor research

Tyrosine kinase inhibitors in cancer therapy

Using cerium-based inhibitors in eCoat paints

© 2024 chempedia.info